Last reviewed · How we verify

NCT05059730: COBRA

Comparison of Bi-environmental Conditions During Occupational Related Activity

Completed NA Last updated 28 September 2021
What this trial tests

NA trial testing Zero Degrees Cold Environment in Hyperthermia in 24 participants. Completed in 10 June 2021.

Timeline
2 April 2021
Primary endpoint
10 June 2021
10 June 2021

Quick facts

Lead sponsorUniversity of Connecticut
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposeother
Enrollment24
Start date2 April 2021
Primary completion10 June 2021
Estimated completion10 June 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Connecticut

Who can join

Adults 18 to 28, any sex, with Hyperthermia or Hypothermia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

BHSAI is developing a computational system that provides early alerts of a rise and fall in core body temperature to help reduce the risk of thermal injury in the field and during training. The goal of the body temperature alerting system is to use it during rest, exercise in the heat and cold. Therefore, the primary purpose of this investigation is to validate a body temperature alerting system using physiological responses that occur during rest, exercise in the heat and cold. Multiple cold ambient temperatures will be validated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hyperthermia

Currently open trials in the same condition.

Other University of Connecticut trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05059730.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing